Organ Transplant Tolerance: Strategies for Immune Acceptance
Goal
Achieve donor-specific immune tolerance so the recipient's immune system accepts the graft without lifelong broad immunosuppression.
Current Mainstay: Immunosuppressive Drugs
- Calcineurin inhibitors: Tacrolimus, cyclosporine.
- Antiproliferatives: Mycophenolate mofetil, azathioprine.
- Corticosteroids: Prednisone.
- mTOR inhibitors: Sirolimus, everolimus.
- Costimulation blocker: Belatacept (CTLA-4-Ig).
Combination regimens balance efficacy and toxicity.
Emerging Tolerance-Induction Approaches
1. Mixed Chimerism
Co-transplantation of donor hematopoietic stem cells creates a chimeric immune system that recognizes the graft as self. Used in some kidney transplant protocols.
2. Costimulation Blockade
Agents like belatacept (blocks CD28-CD80/86) and abatacept prevent full T-cell activation, promoting anergy.
3. T-Cell Depletion
Anti-thymocyte globulin or alemtuzumab deplete recipient T cells pre-transplant, reducing alloreactive clones.
4. Regulatory T-Cell (Treg) Therapy
Ex vivo expanded autologous or donor Tregs infused post-transplant to actively suppress rejection.
5. Tolerogenic Dendritic Cells
Donor-derived DCs treated to induce antigen-specific tolerance.
Challenges
- Protocol complexity and cost.
- Risk of infection, malignancy, and drug toxicity during transition.
- Need for reliable biomarkers to confirm true tolerance.
Ongoing clinical trials aim to make tolerance induction safer and more widely applicable.
Kidney Disease - Related Articles
- Kidney Disease Diet: Managing Symptoms & Supporting Kidney Health
- Natural Ways to Pass a Kidney Stone Quickly & Safely
- Kidney Stones in Women: Symptoms, Pain & Treatment
- Kidney Infection (Pyelonephritis): Symptoms, Causes & Treatment
- Kidney Tubule Cells: Functions in Urine Formation & Fluid Balance
- Soy and Kidney Disease: A Balanced Diet Guide
- Renal Parenchymal Disease: Causes, Symptoms & Treatment
